Back to mobile site

Icosavax Inc. (ICVX) Thoughts Ahead of Ph1 Vaccine - Jefferies

March 22, 2022 7:59 AM EDT Send to a Friend
Jefferies analyst Roger Song reiterated a Buy rating and $50.00 price target on Icosavax Inc. (NASDAQ: ICVX) ahead of Ph1/1b ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login